Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 64.67
(-0.06%)
CNY 64.67
(-0.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -373.81 Million CNY | -121.03% |
| 2022 | 1.82 Billion CNY | 53.19% |
| 2021 | 1.19 Billion CNY | 45.59% |
| 2020 | 819.56 Million CNY | 878.52% |
| 2019 | 83.75 Million CNY | 31.23% |
| 2018 | 63.82 Million CNY | 49.58% |
| 2017 | 42.66 Million CNY | 410.34% |
| 2016 | 8.36 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -2.12 Million CNY | 80.37% |
| 2024 Q2 | -10.82 Million CNY | -127.02% |
| 2024 Q1 | 40.06 Million CNY | 119.23% |
| 2023 FY | -384.39 Million CNY | -121.03% |
| 2023 Q1 | -19.42 Million CNY | -109.54% |
| 2023 Q2 | -48.87 Million CNY | -151.6% |
| 2023 Q4 | -208.37 Million CNY | -93.45% |
| 2023 Q3 | -107.71 Million CNY | -120.42% |
| 2022 Q4 | 203.54 Million CNY | -47.92% |
| 2022 Q3 | 390.82 Million CNY | -35.13% |
| 2022 Q2 | 602.46 Million CNY | -4.53% |
| 2022 FY | 1.82 Billion CNY | 53.19% |
| 2022 Q1 | 631.07 Million CNY | 220.24% |
| 2021 Q3 | 494.11 Million CNY | 330.99% |
| 2021 Q1 | 387.38 Million CNY | 62.92% |
| 2021 FY | 1.19 Billion CNY | 45.59% |
| 2021 Q4 | 197.06 Million CNY | -60.12% |
| 2021 Q2 | 114.64 Million CNY | -70.41% |
| 2020 Q3 | 274.16 Million CNY | 34.37% |
| 2020 Q2 | 204.03 Million CNY | 96.97% |
| 2020 Q1 | 103.59 Million CNY | 204.82% |
| 2020 FY | 819.56 Million CNY | 878.52% |
| 2020 Q4 | 237.77 Million CNY | -13.27% |
| 2019 FY | 83.75 Million CNY | 31.23% |
| 2019 Q4 | 33.98 Million CNY | 72.42% |
| 2019 Q3 | 19.7 Million CNY | 18.55% |
| 2019 Q1 | 13.43 Million CNY | -45.12% |
| 2019 Q2 | 16.62 Million CNY | 23.72% |
| 2018 Q4 | 24.48 Million CNY | 11.01% |
| 2018 FY | 63.82 Million CNY | 49.58% |
| 2018 Q3 | 22.05 Million CNY | 0.0% |
| 2017 FY | 42.66 Million CNY | 410.34% |
| 2016 FY | 8.36 Million CNY | 0.0% |